Feb 28

New Molecular Entities approved by FDA

1. Vyvanse – New River Pharmaceuticals

2. Tekturna – Novartis

3. Tykerb – GlaxoSmithKline

4. Altabax – GlaxoSmithKline

5. Neupro – Schwarz BioSciences

6. Torisel – Wyeth

[…continue reading below…]


7. Letairis – Gilead Sciences

8. Selzentry – Pfizer

9. Ammonia N 13 – Feinstein

10. Somatuline Depot – Biomeasure

11. Doribax – Johnson & Johnson

12. Isentress – Merck

13. Ixempra – Bristol-Myers Squibb

14. Tasigna – Novartis

15. Kuvan – BioMarin

16. Bystolic – Mylan Bertek

New Biologics approved by FDA

17. Soliris -Alexion

18. Mircera – Hoffman-La Roche

Comments are closed.

preload preload preload